The recently reported FIELD study, reported in The Lancet last week, demonstrated the lipid lowering medication fenofibrate to reduce rates of minor amputation in patients with diabetes by 36%. Curiously, rates of more proximal amputation remained the same.

http://tinyurl.com/mzsrnu